Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
O. Troian
Observed names:
O. S. Troian,
O. S. Troyan,
Oleksandra S. Troian,
Oleksandra Troian
Institutions:
Zaporizhzhia State Medical and Pharmaceutical University,
European College of Neuropsychopharmacology,
European Psychiatric Association
Observed institutions:
Zaporizhzhia Medical Academy of Post-Graduate Education Ministry of Health of Ukraine,
Zaporizhzhia State Medical and Pharmaceutical University,
European College of Neuropsychopharmacology,
European Psychiatric Association
ORCID:
0000-0002-6160-4604
Observed ORCID:
0000-0002-6160-4604
OpenAlex ID:
A5087433076
Clinical and neuroimaging aspects of formal thought disorder in schizophrenia: a brief narrative review
2024
·
O. A. Levada
, O. S. Troian
·
Modern medical technology
·
4
Ageadjusted Normative Data and Discriminative Validity of Cognitive Tests in the Ukrainian Adult Patients With Major Depressive Disorder
2021
·
O. S. Troyan
·
Modern medical technology
·
2
PDF
P.745 Vortioxetine treatment elevates serum BDNF levels in MDD patients along with the improvement of cognitive and emotional characteristics
2020
·
O. Troian
, O. Levada
·
European Neuropsychopharmacology
·
1
Phenotypic Characteristics of Major Depressive Disorder and Cerebral Gray Matter Abnormalities According to Voxel-based Morphometry Data
2026
·
Oleg Levada
, Oleksandra Troian
, et al.
·
Proceedings of the Shevchenko Scientific Society Medical Sciences
PDF
Decreased PON1 activity as a biological marker for depressive disorders: a narrative review
2025
·
Oleg A. Levada
, Oleksandra S. Troian
·
Journal of Affective Disorders Reports
P.317 Serum insulin-like growth factor-1 levels in patients with major depressive disorder and change after two months` vortioxetine treatment
2020
·
O. Troian
, O. Levada
·
European Neuropsychopharmacology
P.018 Vortioxetine vs escitalopram regarding cognitive and functional recovery in the Ukrainian cohort of patients with major depressive disorder: An 8-week study
2019
·
O. Troian
, O. Levada
·
European Neuropsychopharmacology
P300 parameters for differential diagnostics of the main etiological types of mild neurocognitive disorders and assessment of treatment effectiveness
2018
·
Oleksandra Troian
, Oleg Levada
Show more works
View as search
Works count:
8
Citation count:
7
H-index:
2
I10-index:
Year
Topic
Type